Literature DB >> 5726296

Varying virulence in rabbits infected with different filamentous types of Histoplasma capsulatum.

L S Daniels, M D Berliner, C C Campbell.   

Abstract

Histoplasma capsulatum filamentous primary isolates and their subcultures are separable into two distinct colonial types (A and B) having different microscopic characteristics. Yeast forms of the A and B types and the parent (P) strains from which they are derived are microscopically indistinguishable. Critically standardized inocula of living P, A, and B yeasts from one strain of H. capsulatum (G-184) were injected intravenously into 12 rabbits. Each type produced progressively debilitating disease, but in varying degrees. Of the 12 animals, 6 died within 2 to 14 weeks. A persisting copious nasal exudate, beginning at or before 1 week, was cultured weekly at 26 C on Mycosel (BBL) agar. Pure cultures of A and B filamentous type colonies were recovered from exudates of animals receiving A and B yeasts, respectively, whereas both filamentous types were isolated from rabbits injected with P yeasts, with B predominating. Only A and B yeasts thus maintained their filamentous integrity during animal passage. It was noted that dissemination of H. capsulatum through the nares of infected rabbits represents a possible hazard to laboratory personnel heretofore unrecognized. It is also a possible means of cross-infecting or sensitizing or cross-infecting and sensitizing animals housed in the same room, if A and B yeasts prove not to be antigenically identical.

Entities:  

Mesh:

Year:  1968        PMID: 5726296      PMCID: PMC315206          DOI: 10.1128/jb.96.5.1535-1539.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  3 in total

1.  Vital staining of Histoplasma capsulatum with Janus Green B.

Authors:  M D Berliner; M E Reca
Journal:  Sabouraudia       Date:  1966-06

2.  Primary subcultures of Histoplasma capsulatum. I. Macro and micro-morphology of the mycelial phase.

Authors:  M D Berliner
Journal:  Sabouraudia       Date:  1968-02

3.  Reduction of a tetrazolium salt in determining growth activity of yeast-phase Histoplasma capsulatum.

Authors:  M E Reca
Journal:  Appl Microbiol       Date:  1968-02
  3 in total
  8 in total

1.  Experimental canine histoplasmosis and blastomycosis.

Authors:  J W Ebert; V Jones; R D Jones; R J Weeks; F E Tosh
Journal:  Mycopathol Mycol Appl       Date:  1971-12-06

Review 2.  Natural history and reactivation studies of experimental ocular histoplasmosis in a primate model.

Authors:  R E Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1982

Review 3.  Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi.

Authors:  B Maresca; G S Kobayashi
Journal:  Microbiol Rev       Date:  1989-06

4.  Characterization of antigens from type A and B yeast cells of Histoplasma capsulatum.

Authors:  W Y Mok; H R Buckley; C C Campbell
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  Virulence differences in mice of type A and B Histoplasma capsulatum yeasts grown in continuous light and total darkness.

Authors:  C C Campbell; M D Berliner
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

6.  Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum.

Authors:  K R Klimpel; W E Goldman
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection.

Authors:  Joshua D Nosanchuk; Beatriz L Gómez; Sirida Youngchim; Soraya Díez; Philip Aisen; Rosely M Zancopé-Oliveira; Angela Restrepo; Arturo Casadevall; Andrew J Hamilton
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells.

Authors:  D M Retallack; E L Heinecke; R Gibbons; G S Deepe; J P Woods
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.